Unmet Medical Need in Treatment of Heart Failure Patients with Atrial ... Business Wire (press release) BUSINESS WIRE)--ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for atrial fibrillation, heart failure and other cardiovascular diseases, today announced that the editorial “Treatment of the ... |
